Net Assets for Thermo Fisher Scientific (TMO)
According to Thermo Fisher Scientific's latest reported financial statements, the company's latest reported net assets is $51.94B USD. Net assets — also called stockholders' equity — equal total assets minus total liabilities. They represent the residual claim of shareholders on the company's assets and roughly track book value over time.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingNet AssetsSwitch metric
Latest period
$51.94B
YoY change
+7.7%
5Y CAGR
+9.1%
Peak year (2025)
$53.41B
Latest annual
$53.41B
Net Assets history chart for Thermo Fisher Scientific (TMO) from 1985 to 2025
Net Assets history table for Thermo Fisher Scientific (TMO) from 1985 to 2025
| Fiscal year | Period ended | Reported | Net Assets | YoY |
|---|---|---|---|---|
| 2025 | $53.41B | +7.7% | ||
| 2024 | $49.58B | +6.1% | ||
| 2023 | $46.73B | +6.3% | ||
| 2022 | $43.98B | +7.8% | ||
| 2021 | $40.79B | +18.2% | ||
| 2020 | $34.51B | +16.3% | ||
| 2019 | $29.68B | +7.6% | ||
| 2018 | $27.59B | +8.6% | ||
| 2017 | $25.41B | +18.0% | ||
| 2016 | $21.54B | +0.9% | ||
| 2015 | $21.35B | +3.9% | ||
| 2014 | $20.55B | +21.9% | ||
| 2013 | $16.86B | +9.0% | ||
| 2012 | $15.46B | +2.8% | ||
| 2011 | $15.04B | -2.1% | ||
| 2010 | $15.36B | -0.5% | ||
| 2009 | $15.43B | +3.4% | ||
| 2008 | $14.93B | +3.0% | ||
| 2007 | $14.49B | +4.1% | ||
| 2006 | $13.91B | +398.0% | ||
| 2005 | $2.79B | +4.8% | ||
| 2004 | $2.67B | +11.9% | ||
| 2003 | $2.38B | +17.2% | ||
| 2002 | $2.03B | +6.6% | ||
| 2001 | $1.91B | -24.7% | ||
| 2000 | $2.53B | +25.8% | ||
| 1999 | $2.01B | -10.4% | ||
| 1998 | $2.25B | +12.5% | ||
| 1997 | $2.00B | +13.9% | ||
| 1996 | $1.75B | +34.9% | ||
| 1995 | $1.30B | +31.3% | ||
| 1994 | $990.30M | +13.4% | ||
| 1993 | $873.00M | +56.3% | ||
| 1992 | $558.40M | +14.8% | ||
| 1991 | $486.50M | +54.0% | ||
| 1990 | $315.90M | +50.0% | ||
| 1989 | $210.60M | +16.0% | ||
| 1988 | $181.50M | +12.2% | ||
| 1987 | $161.80M | +11.0% | ||
| 1986 | $145.80M | +43.5% | ||
| 1985 | $101.60M | — |
Net Assets values are taken from Thermo Fisher Scientific's reported balance sheets (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, Thermo Fisher Scientific (TMO) reported net assets of $53.41B – grew 7.7% year-over-year.
Across 2020–2025 (5 years), Thermo Fisher Scientific net assets produced a CAGR of +9.1% – sustaining 14 straight years of year-over-year growth.
2025 marks the peak net assets at $53.41B, with the historical low of $101.60M recorded in 1985.
Among 8 Healthcare peers, Thermo Fisher Scientific (TMO) ranks 4th; the peer median for net assets is $50.64B.
Thermo Fisher Scientific Net Assets by Year
Thermo Fisher Scientific Net Assets 2025: $53.41B
Thermo Fisher Scientific net assets in 2025 was $53.41B, grew 7.7% from 2024. This figure represents the highest annual value in the available history.
Thermo Fisher Scientific Net Assets 2024: $49.58B
Thermo Fisher Scientific net assets in 2024 was $49.58B, grew 6.1% from 2023.
Thermo Fisher Scientific Net Assets 2023: $46.73B
Thermo Fisher Scientific net assets in 2023 was $46.73B, grew 6.3% from 2022.
Thermo Fisher Scientific Net Assets 2022: $43.98B
Thermo Fisher Scientific net assets in 2022 was $43.98B, grew 7.8% from 2021.
Thermo Fisher Scientific Net Assets 2021: $40.79B
Thermo Fisher Scientific net assets in 2021 was $40.79B.
See more financial history for Thermo Fisher Scientific (TMO).
Sector peers — Net Assets
Companies in the same sector as Thermo Fisher Scientific, ranked by their latest net assets.
| Company | Net Assets | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $194.05B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $94.11B | Healthcare |
| Johnson & Johnson (JNJ) | $81.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.61B | Healthcare |
| AstraZeneca PLC (AZN) | $48.67B | Healthcare |
| Eli Lilly and Company (LLY) | $26.54B | Healthcare |
| Amgen Inc. (AMGN) | $8.66B | Healthcare |
| AbbVie Inc. (ABBV) | -$3.27B | Healthcare |
Frequently asked questions
What is Thermo Fisher Scientific's net assets?
- Latest reported net assets for Thermo Fisher Scientific (TMO) is $51.94B (period ending March 28, 2026).
How has Thermo Fisher Scientific net assets changed year-over-year?
- Thermo Fisher Scientific (TMO) net assets changed +7.7% year-over-year on the latest annual filing.
What is the long-term growth rate of Thermo Fisher Scientific net assets?
- Thermo Fisher Scientific (TMO) net assets compound annual growth rate is +9.1% over the most recent 5 years available.
When did Thermo Fisher Scientific net assets hit its highest annual value?
- Thermo Fisher Scientific net assets reached its highest annual value of $53.41B in 2025.
What was Thermo Fisher Scientific net assets in 2024?
- Thermo Fisher Scientific (TMO) net assets in 2024 was $49.58B.
What was Thermo Fisher Scientific net assets in 2025?
- Thermo Fisher Scientific (TMO) net assets in 2025 was $53.41B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
TMO Overview
Company profile, financial tools, and key metrics
TMO Revenue Counter
Earns $1,433 every second. See per minute, hour, and day.
TMO Earnings Counter
Earns $217.50 per second net profit. See per minute, hour, and day.
TMO Economic Scale
Exceeds Paraguay's GDP. Compare with world economies.
TMO What If Invested
What if you had invested $1,000? See historical returns from any date.
TMO How It Makes Money
Discover visual breakdown of $45.20B in revenue — where it comes from and where it goes.
TMO Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
TMO Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
TMO Daily Price Character
Balanced · 47.1% historical win rate (green days). Streaks & record days.
TMO Buybacks
4.54% TTM buyback yield. Shareholder yield & SBC comparison.
TMO Stock Split History
8 splits on record. Dates, ratios, and cumulative multiple.
TMO Dividend Profile
Yield: 0.38%. Safety: 5/8. See full history.
TMO Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
TMO Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.